Why CG Oncology Stock Surged Nearly 40%: Breakthrough Trial Results and Strong Funding Backing the Rally

CG Oncology (NASDAQ: CGON) delivered an impressive performance today, with shares soaring nearly 40%, moving from $22.37 to around $31.00. The massive surge comes after a series of powerful catalysts…

Continue ReadingWhy CG Oncology Stock Surged Nearly 40%: Breakthrough Trial Results and Strong Funding Backing the Rally